التفاصيل البيبلوغرافية
| العنوان: |
Central Serous Chorioretinopathy Associated with Tadalafil. |
| المؤلفون: |
Alsarhani, Abdulaziz, Alarfaj, Motazz, Alhoutan, Khalid, Alsubaie, Hamad |
| المصدر: |
Case Reports in Ophthalmology; 2022, Vol. 13 Issue 3, p999-1002, 4p |
| مصطلحات موضوعية: |
PHOSPHODIESTERASE inhibitors, TADALAFIL, CHOROID |
| مستخلص: |
We report a case of central serous chorioretinopathy (CSCR) associated with tadalafil, a phosphodiesterase 5 inhibitor medication. In this report, we describe a case of a 59-year-old male who presented with blurred vision in the right eye. On examination, he was noted to have serous macular, pigment epithelial detachments, and increased choroidal thickness. The diagnosis of CSCR was made, and the patient was asked to stop the offending agent. Three months after stopping tadalafil, the patient's visual symptoms and subretinal fluid resolved. In conclusion, prescribing physicians should be aware of tadalafil's ability to decrease vision and cause CSCR. The addition of CSCR to the list of tadalafil's side effects should also be considered. [ABSTRACT FROM AUTHOR] |
|
Copyright of Case Reports in Ophthalmology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder